Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors
Clinical trial NCT04866641 · RECRUITING
Trial details
- NCT number
- NCT04866641
- Sponsor
- Taivex Therapeutics Corporation
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2026-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.